CN108371668B - 具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 - Google Patents
具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 Download PDFInfo
- Publication number
- CN108371668B CN108371668B CN201810157999.9A CN201810157999A CN108371668B CN 108371668 B CN108371668 B CN 108371668B CN 201810157999 A CN201810157999 A CN 201810157999A CN 108371668 B CN108371668 B CN 108371668B
- Authority
- CN
- China
- Prior art keywords
- nano
- hydroxyapatite particles
- hydroxyapatite
- slurry
- ball
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 105
- 239000002245 particle Substances 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 13
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 62
- 239000002002 slurry Substances 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 238000005245 sintering Methods 0.000 claims description 18
- 238000001354 calcination Methods 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 238000000498 ball milling Methods 0.000 claims description 10
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 10
- 239000012065 filter cake Substances 0.000 claims description 10
- 238000010335 hydrothermal treatment Methods 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 5
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 claims description 5
- 230000032683 aging Effects 0.000 claims description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 5
- 229910000388 diammonium phosphate Inorganic materials 0.000 claims description 5
- 235000019838 diammonium phosphate Nutrition 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000009768 microwave sintering Methods 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 29
- 230000005764 inhibitory process Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 16
- 201000001441 melanoma Diseases 0.000 abstract description 15
- 210000004881 tumor cell Anatomy 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 11
- 230000035755 proliferation Effects 0.000 abstract description 4
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 13
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 4
- 201000008968 osteosarcoma Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000003501 co-culture Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001330002 Bambuseae Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000005918 in vitro anti-tumor Effects 0.000 description 2
- 230000005917 in vivo anti-tumor Effects 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 241001494510 Arundo Species 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000000385 effect on melanoma Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000000571 inhibitory effect on melanoma Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/10—Particle morphology extending in one dimension, e.g. needle-like
- C01P2004/16—Nanowires or nanorods, i.e. solid nanofibres with two nearly equal dimensions between 1-100 nanometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/54—Particles characterised by their aspect ratio, i.e. the ratio of sizes in the longest to the shortest dimension
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810157999.9A CN108371668B (zh) | 2018-02-25 | 2018-02-25 | 具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810157999.9A CN108371668B (zh) | 2018-02-25 | 2018-02-25 | 具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108371668A CN108371668A (zh) | 2018-08-07 |
CN108371668B true CN108371668B (zh) | 2020-11-24 |
Family
ID=63017985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810157999.9A Active CN108371668B (zh) | 2018-02-25 | 2018-02-25 | 具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108371668B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224123B (zh) * | 2018-10-11 | 2021-04-09 | 成都迪康中科生物医学材料有限公司 | 具有抑制肿瘤作用的纳米羟基磷灰石复合材料及制备方法 |
CA3087911A1 (en) * | 2018-12-20 | 2020-06-25 | Profeat Biotechnology Co., Ltd. | Composition comprising ferrous amino acid particles and use thereof in manufacture of medicament for treating or ameliorating pancreas-related disase |
CN110496097B (zh) * | 2019-09-12 | 2021-06-01 | 四川大学 | 温控释放纳米羟基磷灰石的促组织修复生物可降解水凝胶 |
CN111643522B (zh) * | 2020-07-01 | 2022-03-15 | 四川大学华西医院 | 纳米羟基磷灰石在制备预防或治疗基底细胞癌的药物中的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101734635A (zh) * | 2009-12-31 | 2010-06-16 | 四川大学 | 一种纳米羟基磷灰石粉体的制备方法 |
CN103232233A (zh) * | 2013-04-26 | 2013-08-07 | 四川大学 | 由羟基磷灰石纳米棒或片构建的多孔纳米陶瓷及制备方法 |
CN104825490A (zh) * | 2015-04-23 | 2015-08-12 | 华东理工大学 | 具有抗肿瘤活性的羟基磷灰石纳米粒子及其制备方法和应用 |
-
2018
- 2018-02-25 CN CN201810157999.9A patent/CN108371668B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101734635A (zh) * | 2009-12-31 | 2010-06-16 | 四川大学 | 一种纳米羟基磷灰石粉体的制备方法 |
CN103232233A (zh) * | 2013-04-26 | 2013-08-07 | 四川大学 | 由羟基磷灰石纳米棒或片构建的多孔纳米陶瓷及制备方法 |
CN104825490A (zh) * | 2015-04-23 | 2015-08-12 | 华东理工大学 | 具有抗肿瘤活性的羟基磷灰石纳米粒子及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
汤薇.羟基磷灰石纳米粒子抗肿瘤活性研究.《中国优秀硕士学位论文全文数据库 医药卫生科技辑》.2013,正文第26页倒数第1段,第26页倒数第1段,第27页倒数第1段. * |
羟基磷灰石纳米粒子抗肿瘤活性研究;汤薇;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20130615;正文第26页倒数第1段,第26页倒数第1段,第27页倒数第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN108371668A (zh) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108371668B (zh) | 具有抗肿瘤作用的纳米羟基磷灰石粒子及制备方法和用途 | |
KR100807108B1 (ko) | 다공성의 β-인산삼칼슘 과립의 제조 방법 | |
CN103495209B (zh) | 自发荧光骨修复磁性缓释微球 | |
CN108498858B (zh) | 二硫化钼纳米片原位修饰生物陶瓷支架及其制备方法和应用 | |
Sumathra et al. | A phosphorylated chitosan armed hydroxyapatite nanocomposite for advancing activity on osteoblast and osteosarcoma cells | |
CN112661500B (zh) | 表面具有微纳米结构的生物陶瓷支架及其制备方法和应用 | |
CN108030956A (zh) | 治疗肿瘤性骨缺损的生物活性玻璃陶瓷支架及其制备方法和应用 | |
CN112625397A (zh) | Peek基复合材料、骨修复体、制备方法和应用 | |
Sukhodub et al. | Effect of magnetic particles adding into nanostructured hydroxyapatite–alginate composites for orthopedics | |
KR20200012815A (ko) | 말뼈 나노세라믹 및 pcl을 포함하는 치주조직 재생용 지지체 및 이의 제조방법 | |
CN113827767B (zh) | 一种用于骨瘤术后组织修复的新型微凝胶骨粉的制备方法 | |
CN107158465B (zh) | 一种骨支架复合材料的制备方法 | |
CN107032775A (zh) | 一种纳米羟基磷灰石、硅酸二钙复合生物陶瓷及其制备方法和应用 | |
Li et al. | Magnetic liquid metal scaffold with dynamically tunable stiffness for bone tissue engineering | |
Liu et al. | Development of a polyacrylamide/chitosan composite hydrogel conduit containing synergistic cues of elasticity and topographies for promoting peripheral nerve regeneration | |
CN112891537B (zh) | 具有抗肿瘤功能的光热电纺纤维膜及其制备方法和应用 | |
Heinemann et al. | Electric field-assisted formation of organically modified hydroxyapatite (ormoHAP) spheres in carboxymethylated gelatin gels | |
CN112972767B (zh) | 一种具有促进成骨作用的磁响应组织工程材料及其制备方法与应用 | |
CN115581810A (zh) | 一种富含外泌体的水凝胶及其制备方法和应用 | |
CN114601969A (zh) | 含黑磷复合材料及其制备方法、应用 | |
TWI769746B (zh) | 天然含鈣廢棄物製備之骨填補物及其製備方法 | |
CN107596439A (zh) | α‑半水硫酸钙骨移植材的制备方法 | |
CN111514372B (zh) | CaCO3/MgO纳米复合物及其在骨修复中的应用 | |
CN104027843B (zh) | 一种植入假体及其制造方法 | |
CN111643522B (zh) | 纳米羟基磷灰石在制备预防或治疗基底细胞癌的药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20180807 Assignee: Sichuan baiamong bioactive materials Co.,Ltd. Assignor: SICHUAN University Contract record no.: X2021980005159 Denomination of invention: Nano hydroxyapatite particles with anti-tumor effect, preparation method and Application Granted publication date: 20201124 License type: Exclusive License Record date: 20210623 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20231123 Contract record no.: X2021980005159 License type after: Common License License type before: Exclusive License |
|
EM01 | Change of recordation of patent licensing contract |